Profile: Accentia BioPharmaceuticals is focused on the commercialization of therapeutics in patent-protected drug delivery technologies related to respiratory, oncology and critical care. SinuNase™ is an amphotericin B suspension that is self-administered into a patient's nasal cavity for the treatment of chronic rhinosinusitis. Rhinosinusitis is an inflammatory condition of the para-nasal sinus that results in a variety of symptoms, including nasal congestion, facial pain and pressure, nasal discharge, and headaches. Respi-TANN® is an antitussive/decongestant combination product that is available as suspension and as chewable tablets. It is ideal for temporary relief of cough, respiratory tract conditions associated with the common cold, influenza, sinusitis, bronchitis, and for the relief of nasal congestion associated with the common cold & acute upper respiratory infections.